57 results
8-K/A
EX-10.1
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
or disposal of hazardous waste, as defined under 40 C.F.R. Parts 260 270 or any state equivalent, which would reasonably be expected to form
8-K
EX-2.1
CHRS
Coherus Biosciences Inc
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
biphenyls, petroleum or petroleum by-products, and (b) any material, waste or substance that is defined, listed or identified as “hazardous
425
8a3030
16 Jun 23
Business combination disclosure
8:08am
425
5gevwjholxrchfqwxnf
16 Jun 23
Business combination disclosure
7:09am
8-K
EX-2.1
6q5q 98z6zp7ppywh
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
8-K
EX-1.1
p3hlyxw3hof
18 May 23
Other Events
5:02pm
8-K
EX-10.1
bczq1lr
7 Jan 22
Coherus BioSciences Secures Credit Financing
8:36am